Neogen (NASDAQ:NEOG) Posts Earnings Results, Beats Expectations By $0.12 EPS

Neogen (NASDAQ:NEOG) posted its earnings results on Friday. The company reported $0.11 EPS for the quarter, beating the consensus estimate of ($0.01) by $0.12, Briefing.com reports. The company had revenue of $231.30 million for the quarter, compared to the consensus estimate of $227.16 million. Neogen had a positive return on equity of 2.80% and a negative net margin of 2.58%. The firm’s revenue for the quarter was up .7% on a year-over-year basis. During the same quarter in the prior year, the business earned $0.11 earnings per share. Neogen updated its FY 2025 guidance to EPS.

Neogen Trading Up 0.7 %

Shares of NASDAQ:NEOG opened at $13.07 on Friday. The company has a market capitalization of $2.83 billion, a P/E ratio of -118.82 and a beta of 1.23. Neogen has a 1 year low of $11.46 and a 1 year high of $18.75. The company has a debt-to-equity ratio of 0.28, a current ratio of 4.41 and a quick ratio of 2.79. The business’s 50 day simple moving average is $13.54 and its 200 day simple moving average is $15.11.

Analyst Ratings Changes

A number of brokerages have commented on NEOG. StockNews.com raised Neogen to a “sell” rating in a report on Monday, September 30th. Guggenheim initiated coverage on shares of Neogen in a research report on Thursday, December 19th. They set a “buy” rating and a $15.00 price target on the stock.

About Neogen

Neogen Corporation, together with its subsidiaries, engages in the development, manufacture, and marketing of various products and services dedicated to food and animal safety worldwide. It operates through two segments, Food Safety and Animal Safety. The Food Safety segment offers diagnostic test kits and related products to detect dangerous and unintended substances in food and animal feed, including foodborne pathogens, spoilage organisms, natural toxins, food allergens, genetic modifications, ruminant by-products, meat speciation, drug residues, pesticide residues, and general sanitation concerns; and AccuPoint Advanced rapid sanitation test to detect the presence of adenosine triphosphate, a chemical found in living cells, as well as provides genomics-based diagnostic technology and software systems that help testers to objectively analyze and store their results and perform analysis on the results from multiple locations over extended periods.